Home
EW
EW News

Latest Edwards Lifesciences Corporation (EW) News on December 25, 2024

Argus Research

a day ago

EW: What does Argus have to say about EW?

DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?

Zacks

2 days ago

DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?

Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?

Insider Monkey

4 days ago

Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?

Is the Options Market Predicting a Spike in Edwards (EW) Stock?

Zacks

5 days ago

Is the Options Market Predicting a Spike in Edwards (EW) Stock?

CMS proposes Medicare coverage for transcatheter tricuspid replacement

MedTech Dive

5 days ago

CMS proposes Medicare coverage for transcatheter tricuspid replacement

MT Newswires

7 days ago

Baird Adjusts Edwards Lifesciences Price Target to $70 From $68, Maintains Neutral Rating

Undervalued Small Caps With Insider Action To Watch In December 2024

Simply Wall St.

7 days ago

Undervalued Small Caps With Insider Action To Watch In December 2024

Argus Research

7 days ago

EW: Raising target price to $65.00

MT Newswires

9 days ago

BofA Securities Upgrades Edwards Lifesciences to Buy From Neutral, Price Target is $90

Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?

Zacks

12 days ago

Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?

Capstan Medical raises $110M for heart valve with robotic system

MedTech Dive

13 days ago

Capstan Medical raises $110M for heart valve with robotic system

MT Newswires

14 days ago

Citigroup Adjusts Price Target on Edwards Lifesciences to $83 From $81, Keeps Buy Rating

Argus Research

14 days ago

EW: Raising target price to $64.00

MT Newswires

15 days ago

Edwards Lifesciences Insider Sold Shares Worth $358,751, According to a Recent SEC Filing

MT Newswires

15 days ago

Edwards Lifesciences Insider Sold Shares Worth $806,406, According to a Recent SEC Filing

Be Wary Of Edwards Lifesciences (NYSE:EW) And Its Returns On Capital

Simply Wall St.

18 days ago

Be Wary Of Edwards Lifesciences (NYSE:EW) And Its Returns On Capital

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

Zacks

20 days ago

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

MT Newswires

20 days ago

Redburn Adjusts Price Target on Edwards Lifesciences to $81 From $80

MT Newswires

20 days ago

Bernstein Adjusts Price Target on Edwards Lifesciences to $72 From $71

MT Newswires

20 days ago

UBS Adjusts Price Target on Edwards Lifesciences to $78 From $75, Keeps Neutral Rating

Edwards expects new TAVR approval in mid-2025 to boost sales

MedTech Dive

20 days ago

Edwards expects new TAVR approval in mid-2025 to boost sales

MT Newswires

20 days ago

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $90 From $81, Keeps Buy Rating

MT Newswires

20 days ago

Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $68 From $63, Keeps Hold Rating

MT Newswires

20 days ago

Truist Securities Adjusts Price Target on Edwards Lifesciences to $78 From $70, Keeps Hold Rating

MT Newswires

20 days ago

Stifel Adjusts Price Target on Edwards Lifesciences to $75 From $70, Keeps Hold Rating

MT Newswires

20 days ago

TD Cowen Adjusts Price Target on Edwards Lifesciences to $75 From $70, Keeps Hold Rating

MT Newswires

20 days ago

Leerink Partners Adjusts Price Target on Edwards Lifesciences to $77 From $74, Keeps Market Perform Rating

MT Newswires

20 days ago

RBC Capital Adjusts Price Target on Edwards Lifesciences to $85 From $80, Keeps Outperform Rating

Morningstar Research

20 days ago

Analyst Report: Edwards Lifesciences Corporation

Edwards Lifesciences Outlines Vision For Growth At Investor Conference

Benzinga

21 days ago

Edwards Lifesciences Outlines Vision For Growth At Investor Conference

MT Newswires

21 days ago

Leerink Adjusts Price Target on Edwards Lifesciences to $74 From $73

MT Newswires

21 days ago

Edwards Lifesciences Provides 2025 Guidance

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Business Wire

21 days ago

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Argus Research

21 days ago

EW: Lowering target price to $63.00

MT Newswires

23 days ago

Barclays Adjusts Price Target on Edwards Lifesciences to $88 From $85

Edwards Lifesciences Corporation's (NYSE:EW) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Simply Wall St.

25 days ago

Edwards Lifesciences Corporation's (NYSE:EW) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock

Zacks

a month ago

New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock

MT Newswires

a month ago

RBC Raises Price Target on Edwards Lifesciences to $80 From $75, Keeps Outperform Rating

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Simply Wall St.

a month ago

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences announces positive results in one year TAVI trial

Clinical Trials Arena

a month ago

Edwards Lifesciences announces positive results in one year TAVI trial

Edwards Lifesciences announces positive results in one year TAVI trial

Medical Device Network

a month ago

Edwards Lifesciences announces positive results in one year TAVI trial

MT Newswires

a month ago

Edwards Lifesciences Says Latest Heart Valve Shows Improved Outcomes Over Older Models

Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data

Business Wire

a month ago

Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data

Despite delivering investors losses of 39% over the past 3 years, Edwards Lifesciences (NYSE:EW) has been growing its earnings

Simply Wall St.

a month ago

Despite delivering investors losses of 39% over the past 3 years, Edwards Lifesciences (NYSE:EW) has been growing its earnings

November 2024's Top Undervalued Small Caps With Insider Activity

Simply Wall St.

a month ago

November 2024's Top Undervalued Small Caps With Insider Activity

MT Newswires

a month ago

Edwards Lifesciences Insider Sold Shares Worth $327,843, According to a Recent SEC Filing

US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024

Medical Device Network

a month ago

US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024

We Like The Quality Of Edwards Lifesciences' (NYSE:EW) Earnings

Simply Wall St.

a month ago

We Like The Quality Of Edwards Lifesciences' (NYSE:EW) Earnings

Argus Research

a month ago

EW: Lowering target price to $59.00

Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight

GuruFocus.com

2 months ago

Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight

Argus Research

2 months ago

EW: Lowering target price to $60.00

MT Newswires

2 months ago

Edwards Lifesciences Insider Sold Shares Worth $1,647,863, According to a Recent SEC Filing

MT Newswires

2 months ago

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $81 From $80, Maintains Buy Rating

Edwards Lifesciences Corporation (EW) Fell Due to Missed Earnings Expectations and Weak Guidance

Insider Monkey

2 months ago

Edwards Lifesciences Corporation (EW) Fell Due to Missed Earnings Expectations and Weak Guidance

Edwards, Medtronic and Inari share trial data at TCT conference

MedTech Dive

2 months ago

Edwards, Medtronic and Inari share trial data at TCT conference

Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation

Business Wire

2 months ago

Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation

TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation

Business Wire

2 months ago

TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation

MT Newswires

2 months ago

Daiwa Downgrades Edwards Lifesciences to Neutral From Outperform, Price Target is $72

Morningstar Research

2 months ago

Analyst Report: Edwards Lifesciences Corporation

JPMorgan views Edwards Lifesciences TAVR data positively

TipRanks

2 months ago

JPMorgan views Edwards Lifesciences TAVR data positively

Bernstein Lifts Edwards Lifesciences Rating, Sees Balanced Risk-Reward in Tavr Market

GuruFocus.com

2 months ago

Bernstein Lifts Edwards Lifesciences Rating, Sees Balanced Risk-Reward in Tavr Market

Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients

Business Wire

2 months ago

Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients

International Markets and Edwards Lifesciences (EW): A Deep Dive for Investors

Zacks

2 months ago

International Markets and Edwards Lifesciences (EW): A Deep Dive for Investors

MT Newswires

2 months ago

Bernstein Upgrades Edwards Lifesciences to Market Perform From Underperform

MT Newswires

2 months ago

Bernstein Upgrades Edwards Lifesciences to Market Perform From Underperform, Adjusts Price Target to $71 From $65

Edwards Lifesciences price target raised to $85 from $80 at Barclays

TipRanks

2 months ago

Edwards Lifesciences price target raised to $85 from $80 at Barclays

Earnings Beat: Edwards Lifesciences Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.

2 months ago

Earnings Beat: Edwards Lifesciences Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Edwards Skids On Weak Expectations For Its Bread-And-Butter Moneymaker

Investor's Business Daily

2 months ago

Edwards Skids On Weak Expectations For Its Bread-And-Butter Moneymaker

Morningstar Research

2 months ago

Analyst Report: Edwards Lifesciences Corporation

MT Newswires

2 months ago

Barclays Adjusts Edwards Lifesciences' PT to $85 From $80, Keeps Overweight Rating

MT Newswires

2 months ago

Jefferies Adjusts Price Target on Edwards Lifesciences to $68 From $70

MT Newswires

2 months ago

JPMorgan Chase Adjusts Price Target on Edwards Lifesciences to $78 From $72

MT Newswires

2 months ago

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $80 From $78

MT Newswires

2 months ago

Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $63 From $66

MT Newswires

2 months ago

Piper Sandler Adjusts Price Target on Edwards Lifesciences to $70 From $73

MT Newswires

2 months ago

Truist Securities Adjusts Price Target on Edwards Lifesciences to $70 From $71

MT Newswires

2 months ago

Citigroup Adjusts Price Target on Edwards Lifesciences to $81 From $77

Edwards Lifesciences Corp (EW) Q3 2024 Earnings Call Highlights: Strong Growth in TMTT Sales ...

GuruFocus.com

2 months ago

Edwards Lifesciences Corp (EW) Q3 2024 Earnings Call Highlights: Strong Growth in TMTT Sales ...

Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics

Zacks

2 months ago

Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics

Edwards Reverses Course, Falling On A Mixed Third-Quarter Report

Investor's Business Daily

2 months ago

Edwards Reverses Course, Falling On A Mixed Third-Quarter Report

Associated Press Finance

2 months ago

Edwards Lifesciences: Q3 Earnings Snapshot

MT Newswires

2 months ago

Edwards Lifesciences Q3 Adjusted Earnings, Net Sales Rise; Sets Q4 Guidance

Edwards Lifesciences Reports Third Quarter Results

Business Wire

2 months ago

Edwards Lifesciences Reports Third Quarter Results

Here’s Why Edwards Lifesciences Corporation (EW) Detracted

Insider Monkey

2 months ago

Here’s Why Edwards Lifesciences Corporation (EW) Detracted

TFX or EW: Which Is the Better Value Stock Right Now?

Zacks

2 months ago

TFX or EW: Which Is the Better Value Stock Right Now?

Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future

Simply Wall St.

2 months ago

Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future

Boston Scientific, Edwards and Dexcom usher in second week of earnings

MedTech Dive

2 months ago

Boston Scientific, Edwards and Dexcom usher in second week of earnings

Edwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks

2 months ago

Edwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Investors in Edwards Lifesciences (NYSE:EW) have unfortunately lost 41% over the last three years

Simply Wall St.

2 months ago

Investors in Edwards Lifesciences (NYSE:EW) have unfortunately lost 41% over the last three years

Earnings Preview: DexCom (DXCM) Q3 Earnings Expected to Decline

Zacks

2 months ago

Earnings Preview: DexCom (DXCM) Q3 Earnings Expected to Decline

Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024

Business Wire

2 months ago

Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024

Artisan Mid Cap Fund Sold Edwards Lifesciences Corporation (EW) as it Failed to Meet Growth Expectations

Insider Monkey

2 months ago

Artisan Mid Cap Fund Sold Edwards Lifesciences Corporation (EW) as it Failed to Meet Growth Expectations

Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Zacks

2 months ago

Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q3 Release

MT Newswires

2 months ago

Edwards Lifesciences Insider Sold Shares Worth $347,534, According to a Recent SEC Filing

MT Newswires

2 months ago

Baird Adjusts Price Target on Edwards Lifesciences to $73 From $70

MT Newswires

2 months ago

Mizuho Adjusts Price Target on Edwards Lifesciences to $78 From $85

Edwards Lifesciences to Report Q3 Earnings: What's in the Cards?

Zacks

2 months ago

Edwards Lifesciences to Report Q3 Earnings: What's in the Cards?

Great week for Edwards Lifesciences Corporation (NYSE:EW) institutional investors after losing 2.4% over the previous year

Simply Wall St.

2 months ago

Great week for Edwards Lifesciences Corporation (NYSE:EW) institutional investors after losing 2.4% over the previous year

MT Newswires

2 months ago

Morgan Stanley Downgrades Edwards Lifesciences to Equalweight From Overweight, Price Target is $70

Argus Research

3 months ago

EW: Raising target price to $62.00

Share on Social Networks: